Crona CORP

Crona Corp. issued 5 million shares of Series B Preferred stock to its executive officers and directors as compensation for past and future work.

Crona Corp. appoints Cheung Lam Hung to its Board of Directors and announces the resignation of two officers, Lucille Zdunich and Demetrios Malamas.

Crona Corp. reported a net profit for Q3 2025, primarily driven by significant debt forgiveness, despite continuing to generate no revenue and facing substantial doubt about its ability to continue as a going concern.

Crona Corp. filed an amended quarterly report to update its industry classification, clarify business activities in funeral services, and correct previously misstated stock balances.

Crona Corp.'s Q2 2025 report reveals no revenue, a significant increase in net loss, and substantial doubt about its ability to continue as a going concern, despite a strategic shift to the memorialization industry.

Crona Corp. reports no revenue for Q1 2025, focusing on its antimicrobial surface protection business and managing ongoing financial challenges.

Crona Corp. reports its third quarter 2024 results, showing no revenue and a net loss, while continuing its transition into the memorialization industry.

Crona Corp. reported no revenue and a net loss of $44,945 for the six months ended June 30, 2024, as it transitions into the memorialization industry.

Crona Corp.'s 10-K filing reveals a net loss of $77,395 for 2024, alongside a shift in business focus to the memorialization industry.

Crona Corp. transitioned from antimicrobial surface protection to the memorialization industry, experiencing a net loss of $193,626 in 2023, and a change in management.

Crona Corp. will implement a 1-for-10 reverse stock split to increase its stock price and improve its attractiveness to investors and potential acquisition targets.